Bone Biologics Corporation Stock Analysis & AI Score
Bone Biologics Corporation (BBLG) has an ST Score of 48.5 (C+), driven by its Growth (A+) and held back by its Momentum (D). BBLG last traded at $0.43.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIBBLG Stock Price History
BBLG Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
BBLG Latest Stock News
ST Score
Bone Biologics Corporation (BBLG) has an ST Score of 48.5 (C+), driven by its Growth (A+) and held back by its Momentum (D). BBLG last traded at $0.43.
- Strongest
- GrowthA+
- Weakest
- MomentumD
All factor grades
- GrowthA+
- Financial StrengthA-
- ValuationB-
- ProfitabilityC-
- MomentumD
- Piotroski1/9
Press Releases
Company Contact Details
BBLG stock: frequently asked questions
What is BBLG's ST Score?
Bone Biologics Corporation (BBLG) has an ST Score of 48.5 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BBLG a buy, hold, or sell?
Our ST Score grades it C+ (48.5/100). The ST Score is a data-driven signal, not a recommendation.
What are BBLG's factor grades?
Valuation B-, Profitability C-, Financial Strength A-, Momentum D, Growth A+.
What is BBLG's valuation grade?
Bone Biologics Corporation (BBLG) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BBLG's growth grade?
Bone Biologics Corporation (BBLG) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BBLG's profitability grade?
Bone Biologics Corporation (BBLG) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BBLG's financial strength grade?
Bone Biologics Corporation (BBLG) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is BBLG's Piotroski score?
Bone Biologics Corporation (BBLG) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.